HomeASTRAZEN • NSE
add
Astrazeneca Pharma India Ltd
Previous close
₹9,139.50
Day range
₹9,076.00 - ₹9,190.50
Year range
₹6,312.75 - ₹10,691.00
Market cap
229.20B INR
Avg Volume
6.36K
P/E ratio
115.06
Dividend yield
0.35%
Primary exchange
NSE
In the news
Financials
Income Statement
Revenue
Net income
| (INR) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 5.59B | 37.03% |
Operating expense | 1.62B | 16.67% |
Net income | 542.20M | 41.09% |
Net profit margin | 9.70 | 2.97% |
Earnings per share | — | — |
EBITDA | 821.80M | 64.90% |
Effective tax rate | 25.54% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 4.00B | -19.49% |
Total assets | 16.15B | 30.07% |
Total liabilities | 8.16B | 45.13% |
Total equity | 7.99B | — |
Shares outstanding | 25.00M | — |
Price to book | 28.59 | — |
Return on assets | — | — |
Return on capital | 22.14% | — |
Cash Flow
Net change in cash
| (INR) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 542.20M | 41.09% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1979
Website
Employees
600
